PLTR

Palantir vs. Ginkgo: The Surprising Biosecurity Battle Investors Can’t Ignore

Palantir (NYSE:PLTR) and Ginkgo Bioworks (NYSE:DNA) are not chasing the same opportunity. One is a high-expectation AI software leader tied to government adoption. The other is a beaten-down biology infrastructure bet. That gap creates the real investor question: where does the biological firewall create the most value? Stock prices used were the market prices of … Read more

Is Palantir the Next Big Winner After the USDA Deal?

(NYSE:PLTR) is now helping manage farmland, supply chains, and government workflows with a massive $300M USDA deal. This could push the company deeper into the government ecosystem and generate significant new growth. But can the stock justify its high valuation, given already soaring expectations? Stock prices used were the market prices of April 25, 2026. … Read more

The Real Reason Palantir Stock Keeps Falling

Palantir (NASDAQ:PLTR) is down sharply, reopening the biggest debate around the stock: is this just a valuation reset, or the start of something worse? I break down the selloff, the Burry warning, and why the financials still complicate the bear case. Stock prices used were the market prices of April 11, 2026. The video was … Read more

15585

You Found Me :)

Now Let's Grow Your Wealth

Learn to invest like the pros—even if you're just starting.

15856